Investigators suggest LDL targets typically reserved for secondary prevention are best in high-risk patients with diabetes.

Recent updates to the National Comprehensive Cancer Network (NCCN) guidelines for cutaneous squamous cell carcinoma (CSCC) ...

At 7 years, the cPFS rate was 67.2% without cabazitaxel and 62.8% with cabazitaxel, indicating no significant effect of cabazitaxel on cPFS (adjusted hazard ratio [aHR], 1.09; 95% CI, 0.85-1.38; P ...

We report the clinical outcomes of a randomized trial comparing prophylactic whole-pelvic nodal radiotherapy to prostate-only radiotherapy (PORT) in high-risk prostate cancer. This phase III, single ...

Impact of piflufolastat F18 imaging on disease management for prostate cancer patients: Observations from the PYLARIFY Registry study. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary ...

Brigham and Women's Hospital investigators link very high lipoprotein(a) with a higher 30-year risk of major cardiovascular events in initially healthy women. Elevated plasma lipoprotein(a) is a ...

In the United States, women have a 1 in 8 chance of developing breast cancer in their lifetime. But some women, due to genetic and biological factors, are at a higher risk. Most women are familiar ...

More patients with hypercholesterolemia at high/very high risk of cardiovascular (CV) events achieved low-density lipoprotein cholesterol (LDL-C) goals with inclisiran compared with placebo, when ...

A nearly 30-year study shows a strong long-term association between very high lipoprotein(a) [Lp(a)] levels and cardiovascular disease (CVD) in women and raises questions about whether broader ...